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 Summary 
Background 
During the past two decades there has been an increasingly focus on cancer risk 
reduction using genetic tests and family history to identify persons with increased risk 
of developing cancer. Depending on the genetic condition, persons at significantly 
increased risk may be identified and then enrolled into long term surveillance 
programs. This is the case for patients with Multiple Endocrine Neoplasia type 
1(MEN1) where nearly 100% develop symptoms. Others may be identified as having 
a slightly increased cancer risk, but no management strategies are made available for 
them. This is the current clinical practice for Norwegian men identified with a 
mutation in breast cancer gene 1(BRCA1) or breast cancer gene 2 (BRCA2). Limited 
research interest has been paid to researching the psychosocial issues of these patient 
groups, the MEN1 patients and men with BRCA1/2 mutations.  
Aims 
The overall aim of this thesis is to explore and describe the experiences of two patient 
groups living with high and slightly increased risk for hereditary cancer.  
Material and methods 
Qualitative semi-structured interviews had been performed with 29 MEN1 patients 
recruited through a specialty clinic in Sweden (Study 1). The data were analyzed in 
line with Georgi’s phenomenological method. To learn about male experiences in 
hereditary breast and ovarian cancer syndrome (HBOC) families, a systematic review 
of existing psychosocial research on this topic was performed, and a thematic 
analysis was utilized (Study 2). Further, 15 BRCA1/2 mutation positive men 
participated in two successive in-depth interviews, and seven female partners 
participated in the second interview (Study 3). These participants were recruited 
through two departments of Clinical Genetics in Norway. A phenomenological 
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 lifeworld approach was utilized, and the in-depth interviews were analyzed using 
Georgi’s phenomenological method. 
Results 
The MEN1 patients with high increased risk described mixed feelings about the 
clinical follow-up program. They experienced decent care from their health care 
providers but they still had unmet informational needs. Their genetic condition was 
associated with pain, job insecurity and feelings of guilt towards their children. They 
also experienced short-term perspective in future planning due to fears that their 
condition might worsen. However, they had adjusted to their situation and described a 
change in their priorities and values. They also defined themselves as healthy. 
A review of the literature regarding men in hereditary breast and ovarian cancer 
(HBOC) families describes women as playing the leading role in communicating 
genetic information in the family. Men`s decision to seek genetic counseling and 
testing is said to be out of family duty or as an obligation to their children. Men are 
described as suffering from intrusive feelings due to unresolved grief and to use 
avoidance as a coping strategy. Previous reports describe men’s feelings of guilt 
towards their children and other family members. Men`s genetic test results may have 
an impact on familial relationships and reproductive decisions. 
The Norwegian men identified as BRCA1/2 mutation positive experienced strong 
emotional reactions after disclosure of their test results including fear of developing 
cancer. The men also felt responsible for other family members’ health, and described 
an unmet need of risk information regarding their own and relatives’ potential cancer 
risk. Due to fear of being stigmatized most participants felt it important to keep the 
genetic information private. Many had not informed their children about the family 
mutation mainly because of their young age, or because they knew that their offspring 
were struggling with difficult life events. Participants also considered it difficult to 
discuss their test results or health related information with other males, and they 
perceived females as their social and emotional support.  
VIII
 Conclusion 
People’s feelings and understanding of genetic risk does not seem to depend on the 
numeric risk estimate. The results from this study pinpoint the need for counseling 
and follow-up strategies for both MEN1 patients and for male BRCA1/2 mutation 
carriers. 
Health care providers may have an impact on how these patients deal with their 
condition, and the patients may also profit from closer contact with community health 
care. There is also a need for future research regarding the psychosocial issues for 
MEN1 patients and BRCA1/2 mutation positive men. 
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 1. Introduction 
Healthcare is increasingly focused on risk reduction, and in recent years there has 
been a drive for cancer genetic risk assessment where genetic tests and family history 
have made it possible to identify persons at increased risk for hereditary cancer. This 
knowledge may lead to preventative interventions where persons at risk are enrolled 
in follow up programs, as is the case for persons with Multiple Endocrine Neoplasia 
type 1 (MEN1). This is a rare genetic condition where nearly 100% develop 
symptoms [3], and persons at risk are therefore enrolled into follow-up programs 
already from a very young age. Little is known about MEN1 patients’ experiences of 
living with high genetic risk of disease, and their experiences of being involved in a 
long-term follow-up program. Persons with slightly increased risk for cancer may 
also be identified, without any management strategies available for them. This is the 
case for male BRCA1/2 mutation carriers. There has been little research interest in 
the psychosocial issues regarding these men, and there is also a lack of risk 
management strategies and guidelines for genetic counseling for BRCA1/2 mutation 
carriers [4]. The focus of this thesis is to explore and describe the experiences of two 
patient groups living with high and slightly increased risk for developing cancer.  
Clinical practice in these fields may benefit from new knowledge in relation to 
genetic counseling and testing. 
1.1.1 Multiple endocrine neoplasia type 1 (MEN1) 
Multiple Endocrine Neoplasia type 1(MEN1) is an autosomal dominant disease 
caused by a germline mutation in the MEN1 localized to chromosome 11q13 [5]. 
Although this condition often is regarded as a treatable endocrinopathy, MEN1 is 
regarded as a cancer syndrome due to lack of effective prevention for associated 
malignancies [6]. This condition is characterized by parathyroid hyperplasia, 
duodeno-pancreatic endocrine tumors, and anterior pituitary adenoma. These cancer 
forms may be present in the same patient or in multiple family members [7]. 
Parathyroid adenomas are the most common feature, and are present in 90% of the 
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cases. In approximately 50%-75% of the cases pancreatic islet cell tumors are seen 
[8]. There is also evidence that other endocrine and nonendocrine neoplasm may be 
common in MEN1. In addition to skin tumors foregut carcinoid, tumors in the central 
nervous system, leyomyomas and lipomas are described [6]. Each child of an 
individual with a mutation in the MEN1 gene has a 50% chance of inheriting the 
disease-causing mutation. Symptoms may develop already from the age of five, and 
the risk of developing disease (penetrance) is nearly 100% increasing with age [3]. 
By the age of 30-40, most affected individuals will have developed symptoms. There 
is however variation in where tumors are localized, onset age, and clinical 
aggressiveness [9]. Persons identified with MEN1 are offered regular life-long 
surveillance as it is important to identify and treat possible new hormonal 
disturbances before serious illness develops [10]. Advances in knowledge from 
surgical and pharmacological interventions have lead to improved clinical 
management [6].  
1.1.2 Hereditary breast and ovarian cancer (HBOC) 
Hereditary breast and ovarian cancer (HBOC) is one of the most common hereditary 
cancer syndromes in the Western world [8]. In Norway 2700 women develop breast 
cancer and 450 are diagnosed with ovarian cancer annually [11]. Of these cases 
approximately 5 to 10 % of breast cancer and ovarian cancer are due to a hereditary 
predisposition. In 50 % of the genetic cases, mutations of the BRCA1 or BRCA2 
(located on 17q and 13q respectively) genes may be involved [12, 13]. Both men and 
women have a 50% risk of inheriting a cancer susceptibility mutation if one of their 
parents has a mutation. In cases where the family-specific mutation is known, family 
members may be identified as mutation positive or negative. The penetrance (i.e. the 
cumulative risk) is not complete, and variable risk estimates regarding lifetime female 
risk of developing breast and/or ovarian cancer are reported. These risk estimates 
vary depending on if they are derived from affected family-ascertained studies or 
population ascertained studies [8]. There is also a great variation in the prognosis of 
the cancer developed [14-16]. The female risk estimates also vary between BRCA1 
and BRCA2, and there is a broad variation among carriers [17]. The lifetime risk (up 
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 to 70 years) for breast cancer is estimated to be 44-78% and 18-54% for ovarian 
cancer for women with a mutation in BRCA1. The cancer risk in women caused by a 
mutation in BRCA2 is reported to be somewhat lower [18, 19]. 
Other studies suggest lifetime risk estimates for developing breast cancer to be 
between 43 and 95%, and an additional risk of developing ovarian cancer up to 60% 
[12]. Four common Norwegian founder mutations located in BRCA1 are estimated to 
confer a risk for breast and/or ovarian cancer up to 80-88% at age 70. In the south-
western part of Norway there is a high prevalence of three local founder BRCA1 
mutations, resulting in a higher incidence of HBOC in this region than in the rest of 
the country [20]. A risk management program including annual mammography and 
magnetic resonance imaging (MRI) is available for female BRCA1/2 mutation 
carriers in Norway. Bilateral salphingo oophorectomy is recommended from the age 
of 35. Prophylactic mastectomy is also available [21]. 
Male BRCA1/2 mutation carriers also have slightly increased cancer risk, but the 
implications on males are still uncertain. A lifetime risk of 6% to 7% of developing 
breast cancer is described in male BRCA2 mutation carriers. The cumulative risk of 
prostate cancer (PRCA) is said to be 20% before age 80 [22]. It is also suggested that 
BRCA1/2 mutation carriers may develop a particularly aggressive PRCA [23, 24], 
and greater risks for pancreatic, gastric and hematologic cancers compared to non-
carriers are reported. The risk for colorectal cancer and melanoma is not clear [4]. It 
is suggested that PRCA cancer may be detected at an early stage by target screening 
of BRCA1/2 mutation positive males [23, 24]. However, there is a lack of genetic 
counseling and risk management strategies for these men [4].  
1.2 Genetic counseling 
Families with hereditary cancer syndromes may seek or be referred for genetic 
counseling and testing. 
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 1.2.1 History of genetic counseling 
The intention of the early activity of providing genetic advice was to prevent certain 
genetic conditions in the society [2]. It is said that the strong tradition of 
nondirectiveness in modern genetic counseling developed as a reaction to the eugenic 
tradition established by Charles Davenport in 1910 [25]. This early tradition 
represented a dark period from the 1920s and during the Second World War. Over the 
years genetic counseling has developed into a communication process which also 
deals with the entire family. In 1947 the modern concept of genetic counseling was 
established by Sheldon Reed, and by 1951 ten genetic counseling centres were 
established in the USA. These centres focused their activity on the medical, 
psychological and social aspects of counseling [25, 26]. 
In 2001, due to the relatively short existence of genetic counseling in the Norwegian 
and Swedish health care system, the first Masters Degree program of health science 
in genetic counseling was established at the University of Bergen, Norway. In 
Sweden the first genetic counselors completed their training in 2005 at Uppsala 
University. However, locally trained genetic counselors have been working in both 
Norway and Sweden for two decades. Genetic counseling practice varies between the 
two countries depending on differences in education and legislation. Genetic services 
are funded by the National Health Service in both countries, theoretically allowing 
for equal access to genetic counseling and testing.  
1.2.2 Definition of genetic counseling 
Numerous definition of genetic counseling exists, but most of the modern definitions 
of genetic counseling are based upon Fraser`s definition from 1974 [27] (p. 637).  
“Genetic counseling is a communication process which deals with the human 
problems associated with the occurrence, or the risk of occurrence, of a genetic 
disorder in a family. This process involves an attempt by one or more appropriately 
trained persons to help the individual or family (1) comprehend the medical facts, 
including the diagnosis, the probable course of the disorder, and the available 
management; (2) appreciate the way heredity contributes to the disorder, and the risk 
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 of recurrence in specified relatives; (3) understand the options for dealing with the 
risk of recurrence; (4) choose the course of action which seems appropriate to them in 
view of their risk and their family goals and act in accordance with that decision; and 
(5) make the best possible adjustment to the disorder in an affected family member 
and/or to the risk of recurrence of that disorder.”  
The current genetic counseling encompasses other aspects than merely providing 
information about disease or hereditary conditions in general [28]. One aim of genetic 
counseling is to achieve empowerment [29] which refers to people’s ability to 
mobilize and strengthen their resources, and neutralize those forces that could lead to 
feelings of helplessness [30]. There are educational, emotional and ethical aspects 
involved in the process of genetic counseling [31], and previous evidence pinpoints 
that the supportive function of genetic counseling can be of greater value for some 
clients compared to the informational component [32, 33]. 
1.2.3 Professionals in Norway and Sweden 
In Norway and Sweden genetic counseling is performed by both genetic counselors 
and medical doctors with a speciality in medical genetics. In this thesis the term 
counselor is used synonymously for both professions.  
In line with Fraser`s definition of genetic counseling [27] the genetic counseling in 
Norway and Sweden is performed by appropriately trained persons. In order to 
empower the individual and the family to understand the medical facts, the probable 
course of the disorder and available management, the counselors are skilled in 
dealing with these issues. Such counseling and familial evaluation for possible 
hereditary cancer syndrome takes place in a clinical genetics department. This 
process requires team work, involving medical geneticists and genetic counselors. In 
addition, the patients with significantly increased risk are offered surveillance 
programs supervised by specialized clinical health professionals depending on the 
management program. Genetic counseling is mandated prior to predictive testing by 
Norwegian law[34]. Such counseling includes options for testing and surveillance. 
This may contribute to making the best possible adjustment to the actual familial 
cancer syndrome.  
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1.2.4 Norwegian laws regulating genetic counseling 
The Norwegian “Biotechnology Act” was introduced in 1994, and revised in 2003. 
This law mandates genetic counseling prior to, during and following predictive, 
presymptomatic or carrier testing. The law also protects persons from genetic 
discrimination and prevents insurance companies and employers from making use of 
genetic information [34]. In the time frame (2000-2001) when data in Study 1 were 
collected, Swedish law was less comprehensive than the Norwegian legislation [35], 
and fewer genetic tests were regulated by Swedish law. The Norwegian law does 
however not mandate genetic counseling prior to diagnostic testing. According to this 
legislation, the genetic counseling should be performed by genetic counselors and 
medical doctors with a speciality in medical genetics. 
According to Norwegian legislation, all persons approaching the health care system 
are defined as patients [36]. In this thesis both symptomatic MEN1 patients and male 
BRCA1/2 mutation carriers will be referred to as patients accordingly. 
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 2. Theoretical perspective and previous research 
2.1 Health and quality of life 
The present study aims at exploring and describing the experience of two patient 
groups living with high and slightly increased risk for hereditary cancer. Quality of 
life (QoL) and the concept of health are important when exploring human experiences 
in health research. QoL and health are complex phenomena. QoL is related to, for 
instance, happiness, well-being, realizing one’s potentials etc, including an evaluation 
of one`s life as a whole. In quality of life research it is important to explore 
subjectivity, as only the persons themselves are able to judge the quality of their lives 
[37]. The concept of QoL has a normative element. Furthermore, it relates to a 
measurement of how an individual experiences life at a particular moment e.g. when 
suffering from a genetic condition or living with a genetic vulnerability [38]. Also, 
the quality of life (QoL) may be closely related to a view of health as a holistic 
property of a person. The concept of health also has a normative component which 
concerns a person’s general ability to realize his or her plans of life or to fulfil vital 
goals in life [39]. The research in health and QoL are rooted in two main traditions: 
Surveys measuring QoL with predefined definitions and operational questionnaires 
and the qualitative tradition: Interview studies based on subjective meaning and 
interpretation in which the phenomenological life-world tradition is rooted.  
The World Health Organization (WHO) regards health to be more than absence of 
infirmity and diseases, and includes physical, mental and social well-being in their 
view of health [40]. Later approaches to studies of health and QoL are inspired by 
this definition, naming it “health related quality of life” [41] The distinction between 
health and QoL may however sometimes become vague as the concepts health status, 
functional status and QoL are used interchangeably [42, 43]. The concept of Health 
Related Quality of Life (HRQoL) refers to measures to investigate how patients 
experience their situation, and concerns psychosocial aspects that are usually not 
explored in the traditional medical research[44]. Health related research measures of 
QoL have become important features, and refers to physical, social, psychological 
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 and existential aspects which may be affected during disease and treatment [45]. 
When individuals undergo a change in their health state, a response shift caused by 
changes in internal standards may have vital importance. Cognitive, behavioural and 
affective issues are involved in the process of adjusting to the change in their health 
status, and may have an impact on assimilating illness.  
Three different outcomes in this adjustment are described [45, 46]. In the first case 
helplessness, frustration and depression may occur because the affected person 
remains focused on controlling the uncontrollable disease or condition. Consequently 
their perceived QoL will be worse than prior to the change in their health status. The 
second outcome described is a response shift caused by changes in internal standards. 
A changed sense of purpose in life may be developed and could result in a 
modification in the conceptualization of QoL. As such, the experience of QoL would 
be at a similar level as before the changed health status. Finally, the third possible 
outcome is to maintain a sense of internal control by changing focus to manageable 
aspects in life and seeking positive role models in how to adjust to the new health 
status, or creating a new sense of purpose in life. These changes may induce a 
response shift that results in changed values and a change in the conceptualization of 
QoL. This may lead to an experience of similar or better QoL compared to perceived 
QoL prior to the change in health status [45, 46]. 
2.1.1 Antonovsky`s salutogenic model of health 
Aaron Antonovsky was a sociologist focusing on medical sociology. His work 
concerned the relationship between stress, health and well-being. In order to create or 
maintain health and well-being his salutogenetic model is focusing on identifying 
patients` health resources and capacities, within the patient him-/herself as well as in 
his/her surroundings, rather than on disease [47].This is in line with the aims of 
genetic counseling, which aims at achieving empowerment [29, 30] by strengthening 
people’s resources and their ability to mobilize and neutralize those forces that could 
lead to helplessness. Antonovsky developed his salutogenic model during his study of 
menopause in Israeli women who had survived concentration camps in the Second 
World War. In spite of their traumatic experiences these women were in surprisingly 
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 good health. His salutogenic model called Sense of Coherence develops during 
childhood and adolescence, and new knowledge suggests that it develops and 
increases throughout the life [48]. The salutogenic model comprises three 
dimensions: comprehensibility, manageability, and meaningfulness. 
Comprehensibility relates to whether the experienced internal and external stimuli are 
perceived as structured, predictable, and explainable. Manageability concerns the 
individuals perceived resources to deal with stressful situations or disease. The main 
dimension in Antonovsky`s theory is the experiences of meaningfulness which is the 
most important issue in creating well-being and health. Important lifetime aspects for 
achieving meaningfulness are interpersonal relationships, existential issues, activities, 
and employment. It is essential that individuals participate in shaping their own 
future, otherwise these aspects of life will be lost over time if they are not invested in 
or experienced as meaningful [47]. The theory refers to a generic understanding of 
how Sense of Coherence may be developed and sustained, thus leading to coping and 
health. This salutogenic model has shown strong positive correlations to perceived 
health, mental health and QoL [48], and studies of several different populations 
relates Sense of Coherence to QoL [49]. 
2.1.2 Risk 
This study is focusing on the experiences of persons living with high and slightly 
increased risk of developing cancer. In the latest decades it has been an increased 
focus on risk factors for healthy persons [50]. Evidence suggests that individuals have 
problems quantifying their risk [51]. There is however also evidence suggesting that 
persons may have a tendency to overestimate their risk because “high risk” is 
associated with access to follow-up programs they otherwise would not be entitled to. 
Previous research suggests some evidence that high risk estimation may have adverse 
consequences for psychological health. However, this evidence is inconsistent [51]. It 
is also argued that a common mistake in risk communication is to convert results 
from group levels into an individual level [52], and that risk interventions among 
healthy individuals may have undesired consequences like introducing uncertainty 
into healthy people’s lives [53, 54]. 
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Risk assessment and communicating risk information are essential in genetic 
counseling [33, 55], and it is important to understand how individuals perceive their 
genetic risk [51]. The individual subjective feeling of risk does frequently conflict 
with the objective risk estimates communicated by the genetic counselor [33]. 
According to Sivell et al. [51] feelings of risk is based on personal experience and 
thereby hard to quantify. Risk perception is described to be influenced by three main 
areas: contextual factors, the nature of potential outcome and numeric probability 
[33]. The first main area that might have an impact on risk perception is said to be the 
contextual factors like family history and the prevalence of the actual condition in the 
population [33]. Sivell et al. [51] regard contextual factors as past experiences, family 
history, environmental factors, occupation, diet and stress/worry to also influence 
perceived risk. The second main factor is the nature of potential outcome which 
relates to the individual perceived severity of the actual condition. According to 
Sivell et al. [51] risk perception for numerous conditions seem to be influenced by the 
personal experiences of the actual disease, and the treatment of the condition. The 
third main factor that effects perceived risk is the individual perceived pre-existing 
numeric probability influence on risk perception. However, an objective numeric 
probability provided during genetic counseling may modify the perceived subjective 
probability for illness. Also, risk perception may change over time if there is an 
alteration in the context, especially if additional family members develop disease 
[33].  
2.2 Previous psychosocial research in MEN1 patients and 
men in HBOC families 
2.2.1 MEN1 patients 
One study regarding QoL in MEN1 patients was identified [56]. Berglund et al. 
monitored the same twenty-nine MEN1 patients included in Study 1 using 
questionnaires at an in-hospital stay and six months later at home. Psychosocial 
outcome measures such as anxiety, depression, intrusion and avoidance changed only 
marginally between the hospital stay and later at home. The findings describe that 
70% of the participants were defined as pessimists, and patients who have a high 
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 burden of disease and treatment showed an increase in depression levels. They also 
scored lower on the General Health and Social Functioning scale than population-
based norm values. It is suggested that MEN1 patients who suffer from severe disease 
and treatment should be offered psychosocial support [56].  
2.2.2 Men in HBOC families 
Few studies had been published regarding male experiences in HBOC families where 
the study focus had been solely on men. Hallowell et al. published three papers from 
the same study where in-depth interviews with 17 men (five BRCA1/2 carriers and 
12 non-carriers), eight partners and four adult children were performed [57-59]. 
Results from this study describe men`s understanding of their role in transmitting 
BRCA1/2 mutations [57], and how male decision-making regarding predictive testing 
for BRCA1/2 mutations may be influenced by females [58]. One paper describes 
males` different strategies for disclosure of genetic information to their children 
varying from total openness to total secrecy [59]. A qualitative study from McAllister 
et al. [60] describes fear of developing cancer, and concern for daughters amongst 
twenty-two men in breast cancer families [60]. Lodder et al. explored the emotional 
implications of genetic testing in twenty-eight males and their partners with 
interviews and questionnaires. Only four men were identified as mutation carriers, 
and a large variation of psychological reactions in these men were reported [61]. 
Adverse psychological reactions amongst twenty-six men undergoing genetic testing 
for BRCA1/2 were reported by Daly et al. [62]. Dudok de Wit et al. [63] also 
explored the experiences, process and outcome of genetic testing for BRCA1 in four 
males. Results from this study describe men`s tendency to deny and avoid discussing 
their emotions and the presence of hereditary cancer in the family [63]. The largest 
male population explored is reported in a study from Liede et al. [64] where more 
than half of the fifty-nine BRCA1/2 mutations positive males reported intrusive 
thoughts regarding their own cancer risk. The motivation for genetic testing was 
however concern for their daughters [64].  
Other studies deal with both male and female experiences in HBOC families, where 
males or gender issues are commented separately. Ormondroyd et al. [65] 
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 interviewed thirteen widows or blood relatives from deceased BRCA1/2 positive 
males where the mutation was detected after the men`s death. All relatives believed 
that such results should be communicated to relatives, and many felt that these results 
had been beneficial for themselves [65]. Two quantitative studies were performed by 
Smith et al. and included both males and females in HBOC families. The first of 
these studies focused on the familial context of genetic testing for BRCA1, and this 
study reports that male mutation carriers experienced significantly more distress if 
they were first tested in the family. Males identified as mutation negative also 
experienced distress if their siblings were identified as mutation positive [66]. The 
second study from Smith et al. concerns fertility intentions after testing for an 
identified BRCA1 mutation. The results indicated that mutation positive men, in 
contrast to the women, are likely to want additional children [67]. In a qualitative 
study d’Agincourt-Canning explored gender issues, responsibility and disclosure of 
genetic information among males and females undergoing testing for BRCA1/2 [68]. 
A review from the same author focuses on genetic testing and gender in relation to 
testing for hereditary cancer [69]. These studies conclude that communicating genetic 
information seems to be a gendered activity where women play the leading role. 
Another quantitative study measures changes in family functioning after genetic 
testing for a BRCA1 mutation [70]. This study reports a negative effect on males’ 
perceived family cohesion in relation to personal history of cancer or care giving 
responsibility for female relatives with cancer. Anxiety and some coping resources 
may also influence on family cohesion.  
2.2.3 Summary of previous research 
It is a lack of knowledge concerning the psychosocial issues regarding MEN1 
patients, as only one study was identified. Results from this study indicated a need for 
psychosocial support among these patients. It is therefore of vital importance that 
more studies are performed. There is a need for both qualitative and quantitative 
studies on how these patients experience their situation.  
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 It also appears to have been little research interest in the experiences of male 
BRCA1/2 mutation carriers. The sparse available studies regarding males in HBOC 
families report fear of cancer, emotional reactions, avoidance, concern for daughters 
and difficulties in communicating genetic risk information. Effect upon family 
cohesion is also described. In the few available studies on men in HBOC families, the 
participation rate of mutation positive males was low. Far more mutation negative 
than mutation positive men participated in these studies. As such, very limited 
knowledge is available regarding BRCA1/2 mutation positive men. Further studies 
are therefore needed in order to provide a deeper understanding of BRCA1/2 
mutation positive men’s experiences.  
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3. Aims of the study 
3.1 The overall aim 
The overall aim of the study was to explore and describe the experience of two 
patient groups living with high and slightly increased risk for hereditary cancer.  
3.1.1 Secondary aims 
To explore and describe the experiences of Swedish male and female MEN1 patients 
(Study1/Paper I).  
 
To conduct a systematic review of the literature to explore and describe the existing 
psychosocial studies of male experiences in HBOC families (Study 2/Paper II). 
 
To explore and describe the experiences of male BRCA1/2 mutation carriers in 
Norway (Study 3/Paper III&IV). 
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 4. Methods 
Three different studies were performed in order to respond to the overall aim 
presented above. 
4.1 Presentation of studies 
Table I 
Study 1: Qualitative research 
interviews with Swedish male and 
female MEN1 patients 
Semi-structured interviews 
Interviews performed by Swedish 
psychologists 
Analysis: Giorgi`s phenomenological 
method 
 
Study 2: A review of existing 
knowledge about men in HBOC 
families 
Analysis: Thematic analysis 
Study 3 : A phenomenological 
lifeworld approach 
In-depth interviews with Norwegian 
BRCA1/2 mutation positive men 
Interviews performed by the principal 
investigator 
Analysis: Giorgi`s phenomenological 
method  
Narrative approach 
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 4.1.1 Swedish MEN1 patients (Study 1) 
The first aim was to explore and describe the experiences of Swedish male and 
female MEN1 patients. These patients have a very high risk of developing cancer, 
and were all included in follow-up programs. None of the participants had attended 
genetic counseling. This study was part of a larger Swedish study focusing on health-
related QoL and hereditary cancer. In this study, the interview guide were rooted in 
the moral philosopher Griffin`s theory about well-being [71]. According to this 
theory, the concept of well-being is defined as a state of possessing those elements 
one would desire if rational and informed. According to Griffin four prudential values 
constitute essential aspects of a person’s overall quality of life; I ) the ability to enjoy 
a certain sense of autonomy, not merely being victim of circumstances beyond one’s 
control; II) the enjoyment of pleasure, life should not contain only pain and suffering; 
III) the enjoyment of a certain level of deep personal relationships, and; IV) the 
enjoyment of having accomplished something in life, making an imprint [71]. These 
prudential values aid in achieving QoL, and are in line with components identified in 
quality of life surveys [38]. It is essential to notice that every individual chooses an 
individual combination of these values [71].  
4.1.2 A systematic review of men in HBOC families (Study 2)  
The second aim of this study was to conduct a systematic review of the literature to 
explore and describe the existing psychosocial studies of male experiences in HBOC 
families. Methods for reviewing trials are well developed [72, 73]. However, few 
methods for synthesis of non-experimental or qualitative evidence are available [72]. 
In our study it was essential to include all available qualitative and quantitative 
research evidence due to the limitation in available studies. Some approaches are 
described to be suitable for the purpose of integrating qualitative and quantitative 
research evidence. Four broad groups of these approaches are described: narrative, 
qualitative, quantitative and Bayesian [74]. In this study a qualitative approach was 
utilized in order to integrate qualitative and quantitative research evidence. In line 
with this approach, the quantitative evidence was converted into a qualitative textual 
form, and a thematic analysis was used in this transformation by identifying concepts 
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 or key findings [74].  
4.1.3 Norwegian BRCA1/2 mutation positive men (Study 3) 
The third aim of this study was to explore and describe the experience of male 
BRCA1/2 mutation carriers in Norway. A phenomenological lifeworld approach was 
chosen to respond to this aim. 
 
The lifeworld concept was developed during the phenomenological movement as part 
of Edmund Husserl’s critique of the “totalization of natural science as a governing 
ideal for science in general, and the view that it had a general superior method to 
attain truth” [75] (p. 30). According to Husserl this totalization runs the risk of a 
dehumanized science, thus creating a crisis of confidence as to the human quest about 
the meaning of human existence [76]. As Dahlberg et al. put it, Husserl wanted to 
“reinstate the everyday world as the foundation of science” [75] (p. 31). Lifeworld, 
then, is partly outlined as the un-escapable foundation for knowing anything at all 
about the world, partly as an object for exploration itself [77]. Thus, the lifeworld 
means “the concrete everyday reality which we encounter and relate to, that of which 
we cannot depart, and which is shared by others [77] (p. 31, translated from 
Norwegian). A lifeworld perspective in the health sciences implies qualitative 
research methods that are governed by openness towards the complexity and variety 
of meanings and values in everyday life. Further, it entails the lived experience’s 
character of cognitions and emotions, perceptions and sensations, as well as sociality 
[78] (p. 38).  
The focus in this qualitative study was to explore and describe human experience of 
living with cancer risk. A phenomenological approach makes it possible to place the 
patients’ lived experiences at the heart of the investigation, as well as doing so in a 
systematic and thorough manner. It provides specific strategies for data collection and 
analysis [79]. In a lifeworld approach, data collection is often performed through 
face-to-face in-depth interviews [80]. In this manner, valuable aspects of and insight 
in, for instance the phenomenon of quality of life, may be added. In Study 3 
qualitative in-depth interviews were performed, and Giorgi`s four step 
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phenomenological method was used in the analysis of the interview texts. However, 
the strong philosophical foundation of phenomenological oriented research in the 
health sciences has not been further explicated in the interpretations of the findings.  
The intention of the phenomenological thinking is to go back to the things themselves 
[81]. By entering the lived world of the phenomena of study interest and ask for the 
participants’ descriptions in their actual situations, one may gain a deeper 
understanding. The present experience is always related to past and future 
experiences [82], as outlined in phenomenology. As such, the participants’ earlier 
experiences from cancer in the family, and future perspectives are essential for 
understanding their present lived experiences. In this sense, it is based on the 
understanding of time as lived experiences focusing on the individual story 
describing the specific context, but simultaneously recognizing patterns in spite of 
variations [83]. In addition, we are all part of the lifeworld and perceive and explore 
the experiences of others from a subject position. It is essential to be aware that as 
researchers we are always already intertwined in the lifeworld, and are thereby bound 
to subjectivity[84, 85]. In this case, the subject position of a genetic counsellor, the 
principal investigator. The experience and knowledge about living with hereditary 
cancer risk is part of the fundament for exploring the participants’ experiences. This 
is also a position to challenge consciously underway, in order to be open in the 
encounters with the participants. 
A narrative approach was utilized in Study 3 (Paper IV) to gain a deeper contextual 
insight into what was identified as the main structure in this study. By focusing on 
each individual’s specific story, this approach makes it possible to grasp the 
participants’ own understanding of their situation [83]. As a narrative story 
traditionally is regarded as a meaningful whole containing a beginning, middle and an 
end, following this structure may open up possibilities to describe the meaningful 
whole from the participants’ perspective. By following each participant’s storyline 
we are able to describe lived time by concretising how the present is coloured by past 
experiences and expectations of the future. At the same time as we are able to 
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 understand (describe) the individual story in context, we also may recognize patterns 
in spite of variations.  
4.2 Participants 
This thesis contains data collected from qualitative semi-structured interviews with 
Swedish MEN1 patients and in-depth-interviews with Norwegian BRCA1/2 mutation 
positive men. 
4.2.1 Swedish MEN1 patients (Study 1) 
The first aim of the study was to explore and describe the experiences of Swedish 
male and female MEN1 patients. The participants were recruited through a specialist 
ward for MEN1 patients in Sweden. Ninety percent of all Swedish MEN1 patients 
come to this particular hospital ward on a regular basis. Written information and an 
invitation to participate in the study were sent together with an appointment time to 
the clinical follow-up program. As this study was part of a larger study, the 
participants were also monitored with questionnaires in the same timeframe and 
location. Results from these questionnaires are described elsewhere [56]. The 
participants were included according to the following criteria; 
- They should have a mutation detected or clinical symptoms of MEN1  
- They should be Swedish speaking  
- They should have no present known psychiatric disease and/or drug abuse 
- They should have no identified distant cancer metastasis  
During a one-year time period in 2000-2001, 16 men and 13 women (29/36) were 
included in the study. Five declined participation, and two were not invited to 
participate due to recent diagnosis. They ranged in age from 28-85 years and 25 had 
undergone prior surgical treatment. Nine had Interferon or chemotherapy treatment. 
None of the participants had attended genetic counseling at the time of the interviews. 
All were included in follow-up programs on a regular basis. The analysis of the 
qualitative interview started in March 2005. 
4.2.2 Norwegian BRCA1/2 mutation positive men (Study 3) 
The third aim of the study was to explore and describe the experience of Norwegian 
19
 male BRCA1/2 mutation carriers. The participants were recruited through two 
departments of Clinical Genetics at University Hospitals in Norway in 2008. They 
were included according to the following criteria;  
- They were men older than 18 years and able to read and understand 
Norwegian 
- They were identified as BRCA1 or BRCA2 mutation positive 
- It was more than six months since the disclosure of their test results 
 
Invitation letters and written information were sent from the two departments to 43 
BRCA1/2 mutation positive males in 19 different families. The authors were not a 
part of this process. The invitation letter also included a postage paid envelope with 
direct contact information for the principal investigator. The males who wanted to 
participate in the study returned the consent form, and the principal investigator 
contacted them by phone. In order to obtain knowledge about male and female 
communication and family dynamics, their current partners were also invited to 
participate in the study. No reminders were sent to those who did not respond to the 
invitation letter. A total of 15 BRCA1/2 mutation positive men from 12 different 
families and seven female partners participated in the study. The males ranged in age 
from 26 to73 years (Mdn=51). One was diagnosed with cancer after the disclosure of 
his test result. This information was not known when he was included in the study 
and came to our attention during the first interview. 
All the males had attended genetic counseling both prior to genetic testing and at the 
disclosure of their test results as required by Norwegian law. Two to six years had 
elapsed since the men received their test results and none of the participants had 
further genetic counseling after the disclosure of their test results. None of the 
participants were enrolled in follow-up programs at the time of the interviews.  
4.3 Data collection 
In this thesis data collection has been performed by qualitative research interviews 
(Study 1 and 3) and through literature search (Study 2).  
Qualitative interviews were performed in order to learn about the participants’ 
experiences of living with hereditary cancer risk. This is described to be a suitable 
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 method for learning about persons lived experiences [80, 86]. According to Kvale 
[80] a professional research interview involves a specific technique of questioning, 
and is said to be semi-structured. He states that it is not an open conversation, nor 
highly structured questionnaire. The interview is conducted according to an interview 
guide containing themes, and may also include certain concrete questions [80]. The 
aim of a qualitative interview is to grasp the participants` experiences as complete as 
possible by describing and understanding the meaning of central themes in the 
participants` lives [80, 87]. However, this may not always be easy, and many 
difficulties may occur during the interview. Issues like reticence to talk, or the 
tendency to talk about everything but the phenomena of interest may occur. In these 
situations it is legitimate to lead the participant back to the subject in focus. It is 
important to distinguish between “directing” and “leading” the participant. In these 
cases “directing” refers to guiding the participant to talk about the phenomena of 
interest. “Leading” however, refers to the researchers attempt to get the participant to 
express particular issues desired and thereby biasing the data [87]. 
4.3.1 Swedish MEN1 patients (Study 1)  
The individual interviews were performed by two Swedish psychologists on the day 
of arrival to the hospital ward. As this study was part of a lager QoL study, the 
participants were also monitored with questionnaires in the same timeframe and 
location. Results from these questionnaires are described elsewhere [56]. An 
interview guide based upon Griffin`s theory [71], validated in a pilot study on an 
empirical views of life, [88] was utilized in the individual interviews. In addition the 
participants were encouraged to expound on issues important to them. Semi-
structured questions also explored the participants’ experiences of living with the 
condition in the family, the consequences upon daily activities and participating in a 
clinical follow-up program. The interviews lasted on average one hour, and were 
recorded and fully transcribed. The principal investigator received both the tapes and 
the written transcripts. 
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 4.3.2 A systematic review of men in HBOC families (Study 2) 
Data collection in the review study was performed by searching in Pubmed, Cinahl, 
Embase, PsyINFO and Cochrane Library. The search terms used were: “Genetic 
counseling” and “cancer risk” and “males”, “risk perception” and “neoplasm” and 
“males”, “risk management” and “counseling” or “counselling” and “males”. The 
first searches were performed in January 2007. Eight studies regarding males only in 
HBOC families were identified and included in the study. Due to the limited sample, 
six studies where males or gender differences in HBOC families were commented 
separately were also identified and included. New searches using the same search 
terms were performed in 2008. 
Studies were included according to the following criteria: 
- Studies regarding males only in HBOC families 
- Studies where males or gender differences in HBOC families were commented 
separately 
Studies describing both males and females but where men were not commented 
separately, were not included in the study.  
Eight studies regarding males only in HBOC families and six studies describing 
males or gender differences were identified. A total of 14 qualitative and quantitative 
methods studies conducted from 1996 to 2007 were identified and included.  
4.3.3 Norwegian BRCA1/2 mutation positive men (Study 3) 
Two separate in-depth interviews were performed in 2008 with a time interval from 
two to five weeks. The interviews were performed by the principle investigator, and 
took place in a local Clinical Genetics Department or at another location preferred by 
the participants. Only the males were included in the first interview, and their current 
partners were invited to participate in the second interview. This was done in order to 
obtain knowledge about male and female communication and family dynamics. In 
seven cases the two interviews were performed with the male only, and seven female 
partners participated in the second interview. One participant was not able to 
participate in the second interview for practical reasons. Between two to eight years 
had elapsed after the disclosure of their test results. An interview guide developed by 
the research group was utilized (see Appendix 9). The interviews lasted on average 
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 40 minutes. Due to technical problems in one interview notes were taken. All other 
interviews were recorded and fully transcribed. The transcriptions were performed by 
trusted administrative staff at one of the Clinical Genetics departments and validated 
by the principal investigator. 
4.4 Analysis 
Giorgi`s phenomenological approach was used to analyse the data in Study 1 (paper 
I) and Study 3 (paper III and IV). In study 3 transcripts from both interviews were 
analysed simultaneously in order to get a complete overview over the participants’ 
stories. A thematic theoretical analysis was utilized in Study 2 (paper II).  
In Study 1 both structured and semi-structured questions have been utilized. In the 
analysis only the responses from the semi-structured questions were taken into 
account as very limited information was obtained from the responses from the 
structured questions. 
4.4.1 Giorgi`s phenomenological analysis 
The data were analysed in accordance with Giorgi`s four step analysis [81]:  
- The first step was to get a grasp of the whole by reading the text thoroughly 
several times, and the tapes from the interviews were listened through 
repeatedly. Especially in Study 1 where the interviews had been performed by 
others than the principal investigator, it was important to grasp nuances in the 
communication between the interviewers and the participants. Some of the 
interview transcripts were also read by co-authors. However, according to 
Giorgi the person analyzing the data need not have been the interviewer [87]. 
In study 2 B it was important to get a complete overview over the participant`s 
descriptions by reading both interviews simultaneously. It was also essential to 
grasp the differences between the men`s perspective and their female partner`s 
experiences.  
- This made the basis for the next step where the attention was drawn to each 
participant and each interview was read again in order to discriminate meaning 
units. In this step the text was broken down to manageable units, and the focus 
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 was on the experiences of living with increased risk of developing cancer. It 
was important according to Giorgi that the discriminations were done 
spontaneously, and a mark was made in the data when a shift in meaning was 
identified. Giorgi recommends using a professional perspective in this process 
of analysis [81], and the principal investigator’s experience and understanding 
of hereditary cancer as a genetic councelor was guiding in this part of the 
analysis. The perceived meaning unit discriminations were defined when the 
researcher became aware of a change of meaning toward a concrete 
description, ad one co-author participated in this process. The focus was on the 
participant`s experiences after learning about their mutation status and their 
experiences of living with a genetic condition. This procedure is defined to be 
science in the context of discovery instead of science in the context of 
verification, and the attention was aimed at catching what was important to the 
participants [81, 87].  
- According to Giorgi, the third step is the heart of the analysis [87]. By 
returning to the early descriptions now delineated into meaning units, the 
everyday language of the meaning units was transformed into professional 
terminology with the attention on the participant’s experiences. It was a 
tension between the general description and the concrete situations described 
by the participants. In this step the process and the concrete formulations were 
discussed between the authors. The intention of phenomenology is to create a 
general description by going through the concrete story, striving to bring forth 
what was important to the individual participant in living with hereditary 
cancer risk [81].  
- In the last step of the analysis the transformed meaning units were synthesized 
into a consistent description regarding the individual participant’s experience. 
In this process all transformed meaning units were considered. It is however 
difficult to describe a general structure based upon only one instance, and 
therefore variations across individuals were made. Several subjects create 
larger variations and improve the ability to notice what is essential at the level 
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 of the phenomenon. Special structures might however be important, and could 
sometimes rely on one single subject.  
The data program NUD*IST (Nonnumeric Unstructured Data Indexing Searching 
and Theorizing) computer software was used to organize and analyze the interviews. 
4.4.2 Thematic theoretical analysis 
In Study 2 a thematic theoretical analyses was utilized. As only limited studies 
regarding men in HBOC families were available, both qualitative and quantitative 
studies were included. A thematic analysis is known to be applied across different 
theoretical approaches, and is regarded as suitable in converting quantitative data into 
a qualitative form [73]. This analysis is also regarded as suitable in areas where few 
studies are available [89]. The data were analyzed in accordance with the six steps 
analysis described by Braun and Clarke [89]; 
- Initially, the articles were read and re-read in order to become familiar with the 
data. Notes were taken and resumes from all the papers were written. The main 
impression from the papers was discussed with two co-authors.  
- Secondly the initial codes from the data were produced. In this process of 
analysis it was a constant moving back to the first step reading the papers 
again in order to secure that the findings in the studies was correctly 
understood. In this part of the analysis the papers concerning men only were 
first coded. Next, the same procedure was performed with the papers dealing 
with men and women where the males were commented separately. Concepts 
or key findings from the quantitative studies were extracted and coded verbally 
in order to transform these into a qualitative textual form as described by Pope 
et al. [73]. 
- In the third step the different codes were sorted into potential themes. In order 
to integrate the qualitative and quantitative evidence, the codes from the 
quantitative studies were also developed into potential themes. 
- Fourthly, the themes were reviewed, securing that all the codes from the data 
had been taken into account.  
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- In the fifth step the themes were defined and named. In this part of the 
analysis, the formulations of the concrete themes were developed. 
- Finally, the report was written. However, writing the paper was a continuous 
process moving back and forth between the various steps in the analysis. 
During the entire process of the thematic analysis, the coding of data and the 
formulation of the concrete themes was discussed between the authors. 
 
4.4.3 Narrative approach 
In order to gain a deeper contextual insight into the main structure in Study 3, a 
narrative approach was chosen. This approach makes it possible to focus on the 
individual story [83] and describes the specific context, but simultaneously 
recognizes patterns in spite of variations. In most interviews the initial question, 
asking the participants to tell how they became aware of the family mutation and their 
decision to perform genetic testing generated a long narrative story. The interviews 
were listened through once more, this time focusing on the fourth core theme as a 
story. In order to create meaning from experience or to describe human experience 
[90], individuals may organize non-systematic encounters into coherent stories [91]. 
These narrative stories are described to contain a beginning, middle and an end [92].  
The study of the participants` responses as narratives and the effort to empower these 
males are also closely related [93]. One important way to understand and give 
meaning to individuals is to organize experiences into a narrative form [93]. By 
letting the participants speak in their own “voices” they are more likely to tell stories 
[93]. In this case the narrative stories contribute to the understanding of their own 
experiences as BRCA1/2 mutation positive.  
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 5. Ethics 
Confidentiality in research is an important issue. In order to protect the participants’ 
privacy, anonymity was ensured during the process of data analysis and presentation 
of the results. Private data that might identify the participants were not reported.  
5.1.1 The researcher`s role 
According to Kvale [80] three ethical aspects are described; scientific responsibility, 
relation to the subjects, and researcher independence [80]. The researcher uses him-or 
herself as an instrument for obtaining knowledge in interviews. It is therefore 
important that the researcher has the sensibility to identify ethical issues and the 
ability to act appropriately upon these issues. In this study the principal investigator 
has been conscious about referring the participants in Study 3 to genetic counseling 
after the interviews in order to avoid the role of a genetic counselor. It was also 
important to be aware of too close interpersonal interactions with the participants to 
maintain a professional researcher’s view. In the study of the Swedish MEN1 
patients, the principal investigator was not in contact with the participants.  
 
5.1.2 Swedish MEN1 patients (Study 1) 
Approval for this study was obtained through the local Research Ethics Committee at 
the Swedish University hospital (see Appendix 1). An invitation letter with 
information was sent together with the time appointment to the clinical follow-up (see 
Appendix 2). At their arrival at the clinic they decided if they wanted to participate or 
not. Voluntary participation and their right to withdraw from the study were 
described in the invitation letter. It was also pinpointed that their potential refusal to 
participate in the study would not have any consequences for their medical treatment. 
The participants were also asked for permission to review data from their medical 
records. The individual interviews were performed by two psychologists. The 
principal investigator received the interview transcripts and the tapes. These data 
have been kept safe and unavailable to others. 
27
 5.1.3 Norwegian BRCA1/2 mutation positive men (Study 3) 
The study was approved by a Regional Scientific Ethics Committee and the 
Norwegian Data Inspectorate (see Appendix 4-5). The participants received an 
information letter together with the invitation to participate in the study (see 
Appendix 6). Voluntary participation and their right to withdraw from the study were 
pinpointed. No reminders were sent to those who did not respond to the invitation.  
Written informed consent was requested and obtained for all participants and their 
partners. Two separate consent forms were obtained in cases where their current 
partner participated (see Appendix 7-8). The written transcripts and tapes from the 
interviews have been kept secured unavailable to others, and will be deleted after the 
study is completed. The Regional Scientific Ethics Committee has permitted that 
these data may be kept until 31.12.11(see Appendix 10). 
 
All participants were offered additional genetic counseling in one of the departments 
of Clinical Genetics after the interviews were completed. Ten participants attended 
genetic counseling after the interviews, and an additional three wanted a new genetic 
counseling session later in time. If some of the participants experienced strong 
emotional reactions after the interviews, a psychologist familiar with genetic issues 
was available for the participants. None of the participants accepted this offer. Some 
of the males were still in the process of integrating the knowledge in their lives when 
the interviews were performed. The interviews might influence upon this process.  
Also, the topics discussed in the interviews included sensitive information, and it was 
important to respect the participants’ personal boundaries. According to Fog [86] it is 
always a balance between only scraping the surface and passing the others “borders”. 
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 6. Results 
The main results from the four papers in this thesis are presented below.  
6.1 Living with Multiple Endocrine Neoplasia. Decent Care- 
Insufficient Medical and Genetic Information (Paper I) 
The first aim of the study was to explore and describe the experiences of Swedish 
male and female MEN1 patients. Four main categories and several subcategories 
were identified; (1) the mixed feelings of being in a follow-up program, (2) the effect 
of MEN1 upon daily activities, (3) coming to terms with the condition, and (4) 
uncertainty concerning the future.  
 
The findings indicate that most of the participants have adjusted to their situation. 
They experienced decent care but lack of information in the clinical follow-up 
program. Needs for informative communication and better access to test results were 
also expressed. The genetic condition had impact on their everyday life by causing 
pain, job insecurity, and feelings of guilt. Despite suffering from physical and 
psychological symptoms, they described themselves as being healthy. However, they 
expressed a change in priorities after developing MEN1 or learning about their 
personal risk. Due to uncertainty regarding their physical condition, the participants 
also described a short-term perspective in future planning. This study concludes that 
these patients are in need of medical and genetic information, and they should have 
access to genetic counseling. 
6.2 Men in the women’s world of hereditary breast and 
ovarian cancer – a systematic review (Paper II) 
The second aim of the study was to conduct a systematic review of the literature to 
explore and describe the existing psychosocial studies of male experiences in HBOC 
families. 
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 A systematic review of the sparse previous evidence identified two main themes; (1) 
women’s influence and (2) the psychological impact on men. Women are described 
to influence male decision-making and to play the leading role in communicating risk 
information in the family. Several studies pinpoint that men`s decision to seek genetic 
counseling and testing is considered as an obligation to their children or a family 
duty. Wives are described to take responsibility for informing family members, 
including children, and males address a need to learn how to communicate genetic 
information. With respect to psychological impact, males are said to suffer from 
intrusive feelings stemming from unresolved grief and use avoidance as a coping 
strategy. Previous research also describes feelings of guilt because they might have 
passed on the family mutation to their children. The men also felt guilty if their 
relatives were identified as mutation positive and they themselves turned out to be 
mutation negative. The review reports that males would use the genetic test results for 
reproductive decisions, and describes impact on familial relationships.  
6.3 Stigmatization and male identity: Norwegian males’ 
experience after identification as BRCA1/2 mutation 
carriers (Paper III) 
The third aim of the study was to explore and describe the experience of male 
BRCA1/2 mutation carriers in Norway in order to gain deeper understanding of their 
situation. Two successive in-depth interviews were performed with 15 males. Seven 
female partners participated in the second interview. Four core themes were 
identified, and this paper presents three of the themes: (1) strong feelings after 
identification as a mutation carrier, (2) difficulties in communicating, and (3) hope 
and thoughts for the future. The participants experienced anxiety, feelings of sadness 
and unfairness after the disclosure of their unfavourable test results. Feelings of 
loneliness and disappointment were also described. Due to fear of being stigmatized, 
most participants felt it important to keep the genetic information private. They also 
described difficulties in communicating with other men about health related issues 
and emotional reactions, and preferred to discuss these issues with women. Many had 
not informed their children about the family mutation mainly because of their young 
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 age, or because they knew that their children were struggling with other difficult life 
events. In some cases their wives communicated the genetic risk information to their 
children. Family secrets were revealed during the genetic testing process, initiating 
emotional reactions new questions. Some of the participants learned that they had 
additional sisters. The participants expressed hope for the future and believed in 
future medications for preventing cancer development. Primarily, however, the men 
hoped that their children had not inherited the mutation. Religious beliefs and hope of 
meeting their deceased relatives after death were present in some of the stories.  
6.4 Cancer worry among Norwegian male BRCA1/2 
mutation carriers (Paper IV) 
The data for this paper is collected from the same interviews as described in paper III.  
This paper presents the fourth core theme: Fear of cancer development. This was the 
main finding in the study, and two narrative patterns represent typical features: (1) 
fear for their own health, including fear of developing cancer and (2) negative 
feelings of responsibility for other family members’ health. The participants’ 
narrative stories started when they learned about the family mutation. In the middle 
they described the process of genetic counseling and testing and their emotional 
reactions. The end of the story was described to be their present situation at the time 
of the interviews.  
 
The first narrative pattern describes how the disclosure of the participants’ 
unfavourable test resulted in fear of developing cancer and a need for additional 
genetic risk information. Emotional reactions due to their test results were expressed, 
and need for emotional and informational support some time after the disclosure of 
their mutation status was described. Being aware of possible cancer symptoms had 
become a part of their everyday-life after learning about their mutation status. At the 
time of the interviews, the participants also questioned whether the future might 
reveal additional knowledge regarding male risk. The second narrative pattern 
describes the men`s feelings of responsibility for other family members’ health. The 
participants expressed that concern for their children was their main motivation for 
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genetic testing when they became aware of the family mutation. After learning about 
their mutation status, the men experienced deep concern for their children and 
siblings, in particular daughters and sisters. Feelings of guilt were also expressed 
especially in relation to daughters. Worries for cancer risk amongst young 
grandchildren were also described. Questions and thoughts regarding actual risks and 
risk reduction options for their female relatives had become part of their everyday 
life. 
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 7. Discussion 
This chapter is divided into three parts: methodological considerations; general 
discussion of the findings and possible implications for clinical practice. 
7.1 Methodological considerations 
The overall aim of the study was to explore and describe the experience of two 
patient groups living with high and slightly increased risk for hereditary cancer.  
Different methodological approaches have been utilized in order to respond to the 
overall aim of the study. This thesis includes analysis of semi-structured qualitative 
interviews with Swedish MEN1 patients performed by persons other than the 
principal investigator, a systematic review of the psychosocial studies regarding 
males in HBOC families, and two successive qualitative in-depth interviews with 
Norwegian male BRCA1/2 mutation carriers. 
 
In Study 1 the findings are referred to as main categories and in Study 2 and 3 as 
themes. However, in light of the learning process during the studies in this thesis, the 
findings in Study 1 also should have been referred to as themes. According to Morse 
[94] the terms categories and themes are sometimes used almost interchangeably in 
completed research. It is however important to distinguish between these two 
concepts. A category is described to be a collection of similar data which makes it 
possible to identify and describe the characteristics. The category itself may also be 
defined, compared and contrasted with other categories. Broader categories may be 
divided into smaller categories (subcategories) [94].  
A theme is defined to be a meaningful “essence” that runs through the data [94] (p. 
727), and captures something vital in the data related to the research question [89]. It 
also represents some patterned response or meaning in the data [89]. As the findings 
in Study 1 are in line with the definition of themes, it should also have been referred 
to as themes. 
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 7.1.1 Swedish MEN1 patients (Study 1) 
The interviews in this study contained originally both structured and semi-structured 
questions. The inclusion of structured interviews must be understood in the context of 
the larger study. However, the structured questions brought little new knowledge, and 
the inclusion of these in the first place may be questioned. The structured part of the 
interviews was not included in the analysis. Vital information was however obtained 
from the semi-structured questions in the study, as they were open and facilitated 
spontaneous, lively and unexpected answers. In qualitative interviews access to the 
participants` stories and experiences is obtained through dialogic conversation [80, 
95]. In this study the participants’ experiences may have been more extensively 
explored. On the other hand, the Swedish researchers wanted to highlight aspects 
already included in the larger study. 29 participants may also be regarded as a large 
sample size in qualitative research. According to Giorgi all data collected have to be 
analyzed [87], and the length of the interviews made it manageable to analyze all 
data.  
 
One issue to discuss is possible loss of non-verbal communication as the interviews 
were performed by other persons than the principal investigator. However, the 
principal investigator had access to the tapes and the transcripts, and listened through 
the tapes carefully. On the other hand, having another researcher analyzing the 
interview data might have brought new insight into the study. Also, according to 
Giorgi the person analysing the transcripts need not have been the interviewer [87]. 
He also suggests that some of the liveliness in the dialogue could be helpful to the 
researcher during analysis, and attended to by listening to the interview records. 
There are a cultural and language differences between Sweden and Norway. The 
interviews were carried out by Swedish interviewers with Swedish participants, and 
the analysis was performed by Norwegians. There are also differences in medical and 
genetic clinical practice and legislation. However, having the Swedish researchers 
who performed the interviews as co-authors contributed to confirm the 
understanding.  
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 It is also important to notice that at the time of the interview only 22 % of the 
participants had an identified MEN1gene mutation. The low number of mutation 
positive participants is in contrast to other studies in the same timeframe who report a 
detection rate of 85-95% for MEN1 in families with suggestive clinical features [96, 
97]. Included participants have, however, been diagnosed with MEN1 either through 
meeting clinical criteria or through genetic testing. Our study did not specifically 
explore if there were differences in how patients experienced their situation or in how 
they experienced follow up between these two groups. 
7.1.2 A systematic review of men in HBOC families (Study 2) 
Due to the limitation in available studies, both qualitative and quantitative studies 
were included in the review. As such, no common quality assessment tool has been 
utilized and the quality of the included studies has therefore not been evaluated. It is 
underscored that the results from the studies are presented differently depending on if 
they derive from qualitative or quantitative studies [74]. Quantitative studies report 
results from numeric data based on questionnaires, while qualitative research 
provides rich descriptions and understanding [98]. This issue may have had an impact 
on the analysis in this study. However, some approaches have been described as 
suitable to integrate qualitative and quantitative research evidence [74]e.g. thematic 
analysis as used in our case. 
7.1.3 Norwegian BRCA1/2 mutation positive men (Study 3) 
A process was initiated during the first interview, and some participants had 
discussed genetic and familial issues with close family members when they returned 
to the second interview. Interestingly, new information appeared in the second 
interview on several levels. This was mainly an advantage in the cases where the 
male participated alone in the two interviews. However, in some cases where their 
female partners participated in the second interview, their partners added information 
about the participants which was embarrassing for the men. For ethical reasons this 
has not been described in the papers. 
 
Most of the male BRCA mutation carriers had many questions regarding their own 
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 and their family situation when they came to the interviews. In some cases it was 
important to respond to the most urgent questions before the interview started. If new 
questions appeared during the interview, the tape recorder was turned off when 
answering questions in order to distinguish between the interview situation and the 
response to their questions. As the principal investigator performing the interviews is 
a genetic counselor, it was crucial to distinguish between this role and the role of 
being a researcher. Otherwise the research interview could easily have turned into a 
therapeutic interview. It is important to distinguish between a qualitative research 
interview and a therapeutic interview [80]. The purpose of the research interview is to 
obtain knowledge of the phenomena investigated. Observed changes in the 
interviewed person are described to be a side effect. In contrast, the therapeutic 
interview seeks for changes in the patient, and knowledge acquired in this situation is 
a side effect of helping the patient [80]. 
In this study it was important to focus on the research situation. At the same time, the 
participants had an unmet need for information and counseling. It is essential to 
notice that a process was initiated in the first interview leading to new information 
about family members or additional questions from the participants when they 
returned to the second interview. This was particularly present in the seven cases 
where the males participated without their partners present in the second interview. 
All participants were offered genetic counseling sessions between the interviews or 
after both interviews were completed. These counseling sessions were performed by 
others than the principal investigator. Several of the participants expressed gratitude 
for having been invited to participate in the study. They also questioned whether 
health professionals deliberately held back genetic risk information regarding males.  
7.1.4 Reliability and validity  
Reliability in qualitative studies is regarded as the trustworthiness of the procedures 
and the data generated, and is also a necessity for the validity in a study [99]. The 
validity of a study refers to the degree that a method investigates what was the 
intention to investigate [80]. According to Malterud [100] the internal validity in 
qualitative research asks whether the study investigates what it was meant to, whereas 
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 external validity asks in what contexts the findings can be applied [100] (p. 484). 
Possible threat to validity in qualitative studies may be caused by researcher’s bias 
like selective data collection or interpretation based on personal perspectives [101, 
102]. Familiarity with the particular phenomena investigated may be either an 
advantage or a drawback, or even both. Being familiar with the phenomena 
investigated may open the possibility for losing important information by overlooking 
nuances [101]. On the other hand, being familiar with the investigated subject makes 
it easier to identify relevant questions to ask, as well as less necessary for the 
researcher to intervene unnecessarily in the dialogue by asking questions in order to 
clarify. In this study the principal investigator is a genetic counselor with long 
standing experience in counseling for cancer. Two co-authors outside of the field of 
genetic counseling have read some of the interview transcripts, and participated in the 
process of analyzing the data. Also, the interviews with the Swedish MEN1 patients 
were performed by others than the persons analysing the data. This may indicate 
valuable distance, but also less knowledge about the situations where the data was 
produced.  
 
Another way of enhancing validity by avoiding researchers’ bias in descriptive 
phenomenological research is the use of bracketing, a term first described by Husserl 
[103]. This relates to the researchers attempt to suspend their own experience, 
judgement and beliefs. This claim might be difficult, if not, impossible, to fulfil, but 
the validity of the results from the study may be increased if the process of bracketing 
means reflecting consciously and openly on these issues and described by the 
researcher [101]. In Study 1, the person analysing the data did not participate in the 
development of the interview guide or in the interviews. As MEN1 is a rare 
condition, both the interviewers and the principal investigator had little clinical 
experience with these patients, which may be considered an advantage as well as a 
drawback. Furthermore, the researcher was very conscious about the knowledge 
obtained during the work of the review paper (Study 2), when starting Study 3. This 
consciousness was based on the awareness of not jumping into conclusions or 
restraining openness when starting Study 3. The understanding of a phenomenon 
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 includes both openness and the researcher’s pre-understanding [75]. In this study it 
was important to be aware of the researcher`s background as a genetic counsellor, and 
it was essential to balance restraining and using pre-understandings. Also, in this 
study two successive interviews were performed, and the principal investigator 
listened to the transcripts from the first interview prior to the second interview. In this 
manner it was possible to verify that information obtained in the first interview was 
understood correctly, and the participants had the opportunity to add new 
information. Also, new information not described earlier appeared in the second 
interview. 
 
Technical accuracy in recording and transcribing is also said to increase reliability 
[80]. In Study 1, the verbal transcripts and the tapes were made available for the 
principal investigator, who investigated the transcripts carefully while listening to the 
tapes. In Study 3 the transcriptions were performed by two trusted administrative 
staff, but the tapes were listened to by the principal investigator and the transcripts 
were checked simultaneously. Technical problems occurred in one interview, and 
notes were taken. All other interviews were recorded and fully transcribed. However, 
it is important to be aware of the transformation and reduction occurring from the 
richness of verbal and non-verbal information in the interview situation from tapes to 
transcripts [93]. In order to recall the non-verbal signals like laughter and cry from 
the interviews in the analysis, the principal investigator listened to the tapes 
repeatedly when analysing the transcripts.  
 
During the entire process of analysis in Study 1 and 3, one co-author guided the 
process. Another co-author also participated in vital discussions during this process in 
Study 3. In Study 2, a thematic theoretical analysis was performed. The identified 
themes and the defining of the concrete formulations of the themes were discussed 
between the authors during the entire research process. Verbatim examples of the 
participants `comments were used in the results sections in Study 1 and 3. This is also 
said to enhance the reliability. It is however important that the examples reflect the 
general responses generated, and not simply picking the most vivid quotations [101]. 
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 It is also suggested that letting another researcher follow the analysis to enhance 
reliability may reduce jumping to conclusions. This might however also be 
questioned because the reduction and search for variation is part of the 
phenomenological analysis and are based on the researcher`s reflection [81]. 
Generally, the researcher (s) must take responsibility for the analysis and the 
interpretations of core meanings. 
 
Reliability may be enhanced by using computerized data analysis packages [101]. In 
Study 1 and 3 the data program NUD*IST (Nonnumerical Unstructured Data 
Indexing Searching and Theorizing) was used to organize and analyze the interviews. 
This data program made it possible to move back and forward between the interview 
transcripts, the preliminary themes and the transformed meaning units. It also made it 
possible to trace prior steps in the analysis. The qualitative studies included in this 
thesis have small sample sizes. It has been said that small sample sizes in the 
reporting in qualitative studies have given the impression that the results have little 
application to other populations [98]. More relevant than reducing the question about 
transferability to sample size is questions related to detailed and contextualised 
descriptions, development of clinically useful insights and/or concepts, interpretations 
of core meanings according to relevant theory, and the level of abstractions reached 
in the analysis. All of this depends on the quality of the research material as well as 
the analysis. Also, the vital distinction between internal and external validity in 
quantitative research is not essential when the aim of the research is not mainly 
generalizability to populations [104]. Malterud [100] defines the external validity of 
qualitative research as: “The findings from a qualitative study are not thought of as 
facts that are applicable to the population at large, but rather as descriptions, 
notions, or theories applicable within a specified setting” [100] (p. 486). An 
important question in our case is for instance concerning what Kvale [80] terms 
pragmatic validity, namely if genetic counselors find knowledge from our studies 
relevant and useful in their clinical practice. 
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 7.2 General discussion of the findings 
The overall aim of this study was to explore and describe the experience of two 
patient groups living with high and slightly increased risk for hereditary cancer. The 
results from both patient groups will be discussed simultaneously in this section. 
Even though the interviews designs of the two patient groups differ, and the 
qualitative interviews were performed by different interviewers, both studies still give 
insight into the participants’ experiences of living with hereditary cancer.  
 
The MEN1 patients experienced good care, but insufficient information in the clinical 
follow-up program. They also described pain, job insecurity, and feelings of guilt 
towards their children. A change in values and short-term perspective in future 
planning after learning about their condition was also expressed. The literature review 
identified females in HBOC families to play the leading role in all genetic activity in 
the family, and men`s decision to seek genetic counseling and testing as a family 
duty. Men are said to suffer from feelings of guilt, intrusive feelings due to 
unresolved grief and to use avoidance as a coping strategy. Their genetic test results 
may have an impact on familial relationships and reproductive decisions. The 
Norwegian BRCA1/2 mutation positive men in this study experienced strong 
emotional reactions including fear of cancer, responsibility for other family members’ 
health and an unmet need for risk information. They also kept the genetic information 
private and perceived females as their social network.  
 
Findings from the studies in this thesis indicate that risk perception and emotional 
reactions do not seem to depend on estimated percentage risk. This is in line with 
previous evidence suggesting that it is difficult to interpret the patients` 
understanding of their risk level [105]. Information about future risk may also bring 
insecurity into people`s lives [54, 106] and become a source of anxiety and worry 
[107, 108]. However, genetic counseling is described to improve the accuracy of 
perceived risk without increasing the fear of cancer [109, 110]. The MEN1 patients 
were in need of genetic information which could have been communicated to them 
through genetic counseling. Males identified as BRCA1/2 mutation positive currently 
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 thought to be at low cancer risk not included in follow-up programs may be 
vulnerable, as they also seem to experience need for emotional or informative 
support. In the present study we learned that these men experienced cancer worries 
after learning about their mutation status. Their anxiety and need for risk information 
may be caused by their lack of enrolment in risk management program or other 
regular clinical contact, in contrast to the MEN1 patients who were enrolled in a 
follow-up program on a regular basis. However, this study also adds knowledge about 
high risk persons mixed feeling of being included in a follow-up program.  
 In contrast to the BRCA1/2 positive men, MEN1 patients had not attended genetic 
counseling prior to the genetic test. Genetic testing for MEN1 is regarded as a 
diagnostic test if the patients have symptoms, and the Norwegian and Swedish law 
does not mandate genetic counseling prior to and following diagnostic testing [34]. 
As such, these patients may be enrolled into follow-up programs without receiving 
any genetic counseling both in Norway and Sweden. Testing their relatives with no 
symptoms will however be considered as predictive testing, requiring genetic 
counseling according to the law [34]. Questions arise as to whether it is acceptable 
that persons suffering from symptoms are not entitled to the same information as their 
healthy siblings prior to a genetic test.  
 
 In this study it has been described that male`s genetic test results may have an impact 
on reproductive issues. This is in line with previous evidence suggesting that genetic 
risk information may have an impact on decision making processes [111]. Both the 
Swedish MEN1 patients and the Norwegian BRCA mutation carriers also expressed 
feelings of guilt towards their children and concern for their offspring’s` future health 
[112-114]. In some countries prenatal diagnosis (PND) and preimplantation genetic 
diagnosis (PGD) for inherited cancer syndromes are discussed [115]. In these 
discussions it seems to be difficult to reach a consensus on what conditions that 
should give access to PND and PGD. However, according to Norwegian legislation 
[34] this option has so far not been available for families with inherited cancer 
predispositions. None of the Norwegian and Swedish participants in this study 
mentioned this option during the interviews. In a potential future ethical debate it 
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might also be drawn a distinction between the two patient groups related to the 
difference in the objective risk and severity in these two conditions.  
Study 2 described low rate of participation among men in HBOC families [116], and 
avoidance as a coping strategy amongst men was reported in some of the reviewed 
studies [116]. Studies report higher anxiety levels among cancer patients who 
declined genetic testing compared to those receiving test results regardless of the test 
results. Also persons who did not want to receive their test results were at risk for 
poorer psychological health [51, 117]. These findings are explained by a way of 
coping through avoidance [118]. We learned from reviewed studies [116] that women 
may have an influence on the men’s decision to request genetic testing [116]. This 
might cause pressure on males that otherwise would not perform a genetic test 
interrupting their intention of coping through avoidance.  
Risk perception may be influenced by factors like family history, the perceived nature 
of the potential outcome and the subjective numeric probability. The subjective 
perceived risk may however be modified during counseling [33]. Studies have shown 
that even though genetic counseling improves the accuracy of risk perception, it is 
still inaccurate after the counseling session [119, 120]. We learned that the male 
BRCA mutation carriers who had attended genetic counseling prior to the testing and 
at disclosure of test results also experienced need for risk information in line with the 
MEN1 patients who had never attended genetic counseling. According to Austin [33], 
the effect of risk communication in genetic counseling at a group level might be 
questioned. She suggests that by reflecting back to the patient issues like family 
history, the perceived severity of the disease and the pre-existing perceived risk 
during genetic counseling, the counselors should enable the patients to become more 
aware of factors that may influence their subjective risk perception [33].  
 
The findings from our study also add knowledge about BRCA1/2 mutation positive 
men`s fear of cancer and need of risk information after the disclosure of their test 
results as well as their feelings of loneliness. Even though their level of cancer risk 
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 did not trigger access to medical follow-up on a regular basis, they still had 
educational and informational needs. They also described need of support in how to 
cope with their own and other family members’ risk. As many participants were 
identified with Norwegian funder mutations with high penetrance [20], and lived in 
areas where these funder mutations are frequent in the population, many had 
experienced cancer and death in female family members. It is said that personal 
experience with the severity of the actual disease may influence on how individuals 
perceive their risk [33, 51]. Also population prevalence of the actual condition in the 
population may influence on risk perception [33]. Previous evidence suggests that 
individuals are primarily concerned with the emotional or supportive elements of 
genetic counseling and are seeking support and ways to cope with their risk [32, 51]. 
One aim in genetic counseling is to aid in empowerment [29]. Support in how to cope 
with their risk, may empower them to deal with their situation.  
 
Both MEN1 patients and male BRCA1/2 mutation carriers experienced feelings of 
guilt, and being responsible for other family members’ health. They also experienced 
psychological pain and problems with communicating their test results to their 
children and other family members. Both patient groups experienced their future as 
unsafe and unpredictable, particularly regarding risk of future disease. It is reported 
that cancer worry is associated with a need for more information [121], and it might 
be questioned whether their need for information enhanced both patient groups fear 
of disease. Previous evidence suggests that coping strategies may have a significant 
impact on health among persons at risk [122] and that patient education is important 
to mobilize and strengthen the individual resources in humans [30]. This corresponds 
well with one of Griffin`s prudential values for QoL of not being victim of 
circumstances beyond one’s control [71]. According to Antonovsky`s Sense of 
Coherence (SOC) model a necessity for experiencing life as meaningful is to have 
some influence over one’s own future and fate [47]. Vital in the SOC model is also 
the concept of comprehensibility which refers to whether human experiences are 
perceived as structured, predictable, and explainable, and is essential in coping with 
health related issues. Informational and emotional support may be crucial to both 
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patient groups in order to enhance comprehensibility and thereby empower them to 
deal with their situation. 
 
Both patient groups living with high and slightly increased risk experienced a change 
in their health status due to disease or mutation status. Response shift is described to 
be a change in self-evaluation due to changes in health status [45]. This concept is 
rooted in the quantitative tradition of measuring QoL, and is thereby not in line with 
terminology rooted in the phenomenological tradition. However, the participants in 
this study described changes in their health status which may be associated with the 
response shift model. Both groups described a change in their lives after receiving 
their unfavourable test results or being diagnosed with a genetic condition. The 
physical healthy BRCA1/2 mutation positive men changed their focus and became 
more focused on possible cancer symptoms. MEN1 patients however, where many 
suffered from severe physical symptoms due to their condition, described having 
adjusted to the situation by changing their values. According to their new values, they 
considered themselves as healthy despite of physical symptoms. This is in line with 
the response shift model which is defined as a change of the individual subjective 
experience of QoL due to changes in internal standards, values and the perception of 
QoL [46]. However, individuals also have cognitive, affective and behavioural 
strategies like coping, social comparison and social support, goal recording, 
reframing of expectations and spiritual practices that may be involved in adapting to 
new situations [46]. According to Antonovsky, change of values may also be 
connected to the experience of meaningfulness [47].  
 
In contrast to the MEN1 patients, the BRCA1/2 mutation positive men had not 
changed their internal standards or values in order to adjust to the situation when two 
to six years had elapsed since the males received their unfavourable test results. This 
difference may be due to the change in the perception of their health status from the 
identity of healthy into a person at risk, and “the source” of their children`s risk. Also, 
no available surveillance was made available for these men. In contrast, many of the 
MEN1 patients had suffered from clinical symptoms for many years without 
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 receiving proper medical care at their local hospitals. Being diagnosed with MEN1 
resulted in inclusion into a follow-up program which may have improved their QoL. 
According to the response-shift model, the BRCA1/2 mutation positive men were not 
able to maintain a sense of internal control after learning about their mutation status, 
and their perceived QoL may have been reduced. This is in line with findings 
amongst persons with increased risk of inheriting a mutation in p53, another gene 
involved with a hereditary cancer syndrome, where cancer worry was associated with 
lower QoL and increased perceived cancer risk. [123]. Information about the 
mens`BRCA1/2 mutation status may have been experienced as a threat to the male 
identity facing a potential uncontrollable situation. It is said that masculine health is 
associated with a position of control and invulnerability [124].  
 
The BRCA1/2 mutation positive males` problems in coping with this situation may 
also be due to lack of social network. From the findings in Study 2, we have learned 
that males in HBOC families seemed to be less able to communicate their BRCA1/2 
test results than women [125, 126], and might have limited social support. In Study 3 
we learned that men rarely discussed their mutation status or other health related 
issues with other men [113], and preferred to communicate with women in these 
matters. It is said that open communication regarding hereditary cancer and partner 
support may protect against hereditary cancer distress [127]. Social support may also 
be essential in dealing with disease-related stress [122], and lack of support and 
protective buffering were associated with greater distress among women testing for 
BRCA1/2 [128]. It is described among persons testing for Huntington disease that 
special attention should be paid to networks during genetic counseling, as persons 
with limited social network might be more vulnerable to depression [129]. This is in 
line with one of Griffin`s prudential values for QoL which pinpoints the importance 
of a certain level of deep personal relationships [71]. This view is also consistent with 
the concept of manageability which is another constituent in Antonovsky’s theory 
referring to individuals’ ability to perceive available resources [47].  
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In contrast to the MEN1 patients, the BRCA1/2 mutation positive men appeared 
physical healthy since they had no visible signs or symptoms of their condition. Still 
they kept the information about their mutation status private, and had no contact with 
the health care system on a regular basis. Their desire to keep the genetic information 
private, may also be due to the fact that men in general tend not to make use of the 
health care system in the same manner as women [130].  Health care providers could 
however have represented a social network, and thereby have been perceived as 
available resources. The MEN1 patients included in a follow up program were 
diagnosed with a genetic condition, and many had physical symptoms. In contrast to 
the BRCA1/2 mutation positive men, they also met with others patients in the same 
situation in the specialty hospital ward, and were able to share information and 
experiences. However, even though the MEN1 patients experienced good care, they 
still were in need of medical and genetic information [112]. Their need of information 
was often related to test results which were not available when they left the hospital 
ward after their regular follow-up. These test results were closely related to an 
uncertain future with regard to potential development of disease. 
 
Living with increased risk of developing cancer may be regarded as a chronic 
condition. According to the World Health Organization (WHO) the self management 
of patients with chronic disease should be strengthened [131]. In order to cope 
effectively with their condition on a daily basis, these patients must be provided with 
adequate tools and knowledge. In this way male BRCA1/2 mutation positive and 
MEN1 patients should be empowered to cope with their situation after having 
received information about a genetic vulnerability, or developed symptoms of illness. 
It is said that if risk information should be effectively utilized in health care 
management, the genetic information needs to be communicated outside the genetic 
services [132]. One way to provide these patients access to information and support 
networks is to increase contact and collaboration between the genetic departments in 
hospitals and the community health care. This does however require that the 
community health care is equipped with sufficient knowledge. Health issues 
suggested to improve collaboration between different levels of care have been 
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 emphasized by the National Health Plan for Norway (2007–2010) [133]. Patients in 
our studies have experienced lack of knowledge when they addressed questions to 
their local GP [114]. This is also in line with findings amongst women in HBOC 
families [134]. In this study we have learned that some MEN1 patients had been ill 
for several years without receiving the proper diagnosis at their local hospitals. They 
did not receive the proper diagnosis and care before they were admitted to the special 
hospitality ward [112]. Also, these patients pessimistic outlook reported by Berglund 
et al. [56] seem to be related to difficulties in coping with an uncertain future, due to 
lack of information that could have been provided to them by their local GP.  
 
Another reason for the reluctance to contact their local GP regarding their genetic 
condition might be fear of genetic discrimination. Both MEN1 patients and male 
BRCA1/2 mutation carriers feared that this genetic information might harm 
themselves or their children [112]. It is said that genetic discrimination may cause 
psychological distress [135] and could prevent people from genetic testing [136]. It is 
also reported that in addition to insurance companies, persons perceived genetic 
discrimination coming from health care providers, family, or other social or health 
domains [137, 138].  
                                                                                                                                                               
Several male BRCA1/2 mutation carriers received advices during genetic counseling 
to keep their mutation status private [113]. This advice may contribute to maintain 
their feelings of loneliness [113]. Their fear of being stigmatized also seemed to 
prevent them from addressing these questions with their community health care 
providers. There was however differences in how the two patient groups addressed 
their health related problems with health care professionals. MEN1 patients had 
contact with health professionals who had special knowledge about their condition on 
a regular basis, whilst the male BRCA1/2 mutation positive felt abandoned after the 
disclosure of their test results, and experienced lack of genetic knowledge amongst 
their GP`s. Besides, they were also considered healthy as long as no symptoms have 
occurred, in contrast to MEN1 patients where almost all develop symptoms. Besides, 
health- care providers may not regard breast cancer as a male disease [64], and men 
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 in HBOC families are often excluded from studies concerning psychological distress 
because of their low cancer risk [139-141].  
 
It is vital that both patient groups regard their local GP`s as available resources. The 
population density in Norway and Sweden is low, and many of the MEN1 patients 
may live far from the specialty hospital ward. The male BRCA1/2 mutation positive 
men have in most cases no contact with the genetic departments after the disclosure 
of their test results. In both patient groups a change with regard to their context of 
risk perception may occur if additional family members develop cancer. The 
participants risk perception may therefore change accordingly over time, and it is 
essential that both patient groups have available resources in their local areas. 
 
7.3 Clinical implications 
Our studies indicated that both patients with high and slightly increased risk of 
developing cancer are in need of educational and emotional support. The results from 
this study also pinpoint the need for counseling strategies, guidelines and follow-up 
programs for both patients diagnosed with MEN1 and male BRCA-1/2 mutation 
carriers. MEN1 patients despite being included in a follow-up program for many 
years are in need of genetic and medical information. This may also be due to lack of 
genetic counseling as none of the MEN1 patients in the study had attended such 
consultations. These patients should have access to genetic counseling even in cases 
where the test is diagnostic and counseling is not mandated by law. MEN1 patients 
pointed out that they often were unable to understand the content of medical test 
results performed in the hospital sent to them by mail, causing an uncertain future. 
Therefore, results from their medical test results should be provided to them either by 
phone or face to face in order to ensure that they understand the information. Their 
local GP`s should also have been included in providing these test results.  
 
Most of the BRCA1/2 mutation positive men accepted the offer for additional genetic 
counseling after the interviews. It is important to be aware of their need for emotional 
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 support and ways to cope with their risk as this is said to have greater importance in 
the genetic counseling sessions than purely informational aspects [32, 51]. This may 
indicate a need for additional genetic counseling sometime after the disclosure of the 
test results. It would be essential to offer support on how to share genetic risk 
information with children and other family members. Although they themselves do 
not have very high risk of developing cancer, they experienced responsibility for 
other family member`s health, in particular their daughters. Information about risk 
reduction options and surveillance programs for women should also be included in 
genetic counseling sessions for BRCA1/2 mutation positive males as many of the 
participants questioned this issue. The findings in this study also pinpoint that males 
do not communicate about genetic risk or health issues in the same manner as women 
[125, 142].  
 
Male BRCA1/2 mutation carriers questioned their potential cancer risk, and wanted 
to receive information on a regular basis as they expected knowledge to improve in 
the future. There has been a change in the surveillance program for BRCA1/2 
positive women as knowledge improves, and hopefully the understanding and 
management of male risk will also improve in the future. Recent evidence shows that 
PSA screening detects clinically significant prostate cancer in BRCA1/2 mutation 
positive men compared to the non-carrier control group [143]. There is also evidence 
to support that these men tend to develop a more aggressive cancer [143]. This raises 
the question on whether or not a surveillance program for male BRCA1/2 mutation 
carriers should or can be established in Norway. 
 
One should be aware of both patient groups’ feelings of being stigmatized, and health 
care providers should focus on how to prevent the patients’ feelings of stigma. These 
ppatients might also profit from closer contact with community health care providers. 
The findings in this study also pinpoint the need for counseling strategies regarding 
risk information and strategies for empowering persons with both high and slightly 
increased risk of cancer to cope with their genetic condition. Health care providers 
may have a significant influence upon how persons with MEN1 and male BRCA1/2 
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mutation positive male cope with their genetic risk. The patients should be provided 
with adequate tools and knowledge to cope effectively with their condition on a daily 
basis. Better contact and collaboration between the clinical genetic departments and 
the local health care providers should be established in order to provide better care for 
these patients. So far, there are no international guidelines for counseling strategies 
for MEN1 patients or male BRCA1/2 mutation carriers. This is also reflected in the 
sparse available studies. Manner in which risk information is provided and timing of 
such information is important. It is said that genetic counselors should not use words 
like “high or low chance” in their clinical practice because individuals experience and 
perception and contexts may be different [33, 144]. Several genetic counseling 
sessions may be necessary in order to obtain optimal information about their actual 
situation for both these patient groups. The way these patients are counselled should 
also be evaluated.  
 
In order to develop new guidelines, research findings must be implemented into 
clinical practice. Systematic reviews or research syntheses are essential in 
transferring research evidence between researchers and healthcare decision-makers 
[145]. It is however pinpointed that it is important to distinguish between research 
evidence as knowledge-support providing general background information and 
evidence for decision-support in a particular context [73]. Health care providers 
working in this field must also have sufficient skills about research methodology to 
transform research findings into clinical practice [146]. So far, there has been little 
research interest for the psychosocial issues for both these patients groups, and more 
studies are needed to provide insight about their experiences. 
7.4 Implications for future research 
The present findings raise new research questions. Further studies are needed to 
provide optimal care for both MEN1 patients and men seeking genetic counseling for 
hereditary breast and ovarian cancer. Future studies should explore how patients with 
MEN1 might profit from genetic counseling, and whether or not genetic counseling 
may have positive influence in dealing with their condition. Studies regarding their 
50
 informational and emotional needs in the follow-up program should also be 
conducted.  
 
Further exploration on male emotional reactions including cancer fear after being 
identified as BRCA1/2 mutation positive should be conducted on other populations 
with 	
				Studies should also explore 
the impact on male social network and how genetic counseling may empower males 
to cope with their situation. One should also investigate the impact on partner’s 
participation in the genetic counseling sessions. Research should be performed on the 
effect of follow-programs, and how health care providers may empower these 
patients to cope with their situation. 
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8. Conclusions 
Feelings and understanding of genetic risk does not seem to depend on the numeric 
risk estimate. The results indicate that patients with both high and slightly increased 
risk of developing cancer are in need of educational and emotional support.  
 
- Health care providers may have a significant influence upon how persons with 
MEN1 and male BRCA1/2 mutation positive male cope with their genetic risk 
on a daily basis. Patients with slightly increased risk, such as BRCA1/2 
mutation positive men, with no indication for access to medical follow-up may 
have an unmet need of information.  
- MEN1 patients described change in their personal values in order to adjust to 
their situation. This was not described among male BRCA1/2 mutation carriers 
and these men had not adjusted to their new health status.  
- MEN1 patients` clinical follow-up program seems to play an essential part in 
these patients` lives, but they still described a need for genetic and medical 
information. They also had to deal with physical and psychological pain, lack 
of control over the progression of the disease and were facing an uncertain 
future. However, most patients had adjusted to living with the condition in 
their everyday life. These patients should have access to genetic counseling in 
the same manner as persons seeking predictive genetic testing. 
- According to the sparse available previous evidences regarding men in HBOC 
families, these men worry about their own and their daughters` health, and are 
emotionally affected by the experiences of cancer amongst female relatives. 
Women are said to have an influence on male decision-making regarding 
genetic testing, and seem to play the leading role in communicating genetic 
information in the family. More research is needed about psychosocial 
consequences.  
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 - Male BRCA1/2 mutation carriers experienced strong emotional reactions after 
learning about their mutation status, including fear of developing cancer and 
feelings of responsibility for other family members’ health. Their needs of 
information were inadequately served. There is a need for counseling and 
follow-up strategies for BRCA1/2 mutation positive men. Contact with local 
health care providers should be established after the disclosure of their test 
results.  
This study adds valuable insight into the experiences of two patient groups where 
little previous evidence exists. 
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